
Sign up to save your podcasts
Or


Episode 3 discusses access to treatment disparities for nasal polyposis in minority and underserved populations.
Today’s speakers have the following disclosures:
Gerald Lee, MD: Nothing to disclose
Maha Mahdavinia, MD, PhD: Consulting, Fee: Optinose
This podcast series is supported by Sanofi Regeneron.
By allergytalk5
5050 ratings
Episode 3 discusses access to treatment disparities for nasal polyposis in minority and underserved populations.
Today’s speakers have the following disclosures:
Gerald Lee, MD: Nothing to disclose
Maha Mahdavinia, MD, PhD: Consulting, Fee: Optinose
This podcast series is supported by Sanofi Regeneron.

90,820 Listeners

44,006 Listeners

32,175 Listeners

38,836 Listeners

499 Listeners

2,449 Listeners

3,357 Listeners

112,586 Listeners

56,830 Listeners

1,146 Listeners

50 Listeners

371 Listeners

185 Listeners

2 Listeners

5 Listeners